Methyl 3-fluoro-4'-(2-(1-(2-hydroxyethyl)-5-neopentyl-1H-imidazol-2-yl)ethyl)biphenyl-2-carboxylate

ID: ALA4482945

Chembl Id: CHEMBL4482945

PubChem CID: 155539847

Max Phase: Preclinical

Molecular Formula: C26H31FN2O3

Molecular Weight: 438.54

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1c(F)cccc1-c1ccc(CCc2ncc(CC(C)(C)C)n2CCO)cc1

Standard InChI:  InChI=1S/C26H31FN2O3/c1-26(2,3)16-20-17-28-23(29(20)14-15-30)13-10-18-8-11-19(12-9-18)21-6-5-7-22(27)24(21)25(31)32-4/h5-9,11-12,17,30H,10,13-16H2,1-4H3

Standard InChI Key:  UJGZCLQFQICXLS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4482945

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.54Molecular Weight (Monoisotopic): 438.2319AlogP: 4.84#Rotatable Bonds: 8
Polar Surface Area: 64.35Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.25CX LogP: 5.34CX LogD: 5.13
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.51Np Likeness Score: -0.79

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source